What are the symptoms of Granulomatosis with Polyangiitis (GPA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Symptoms of Granulomatosis with Polyangiitis (GPA)

Granulomatosis with polyangiitis presents with a characteristic triad of upper respiratory tract, lower respiratory tract, and renal involvement, though the clinical spectrum ranges from localized disease to fulminant multisystem vasculitis. 1, 2

Upper Respiratory Tract Manifestations (Most Common Initial Presentation)

The upper respiratory tract is involved in 70-100% of cases and often represents the first clinical manifestation 3:

  • Nasal symptoms: Chronic nasal crusting, stuffiness, and epistaxis (nosebleeds) are hallmark presenting features 2
  • Chronic rhinosinusitis with possible nasal polyps that commonly recur after surgical excision 2
  • Nasal septal perforation can develop in advanced cases 2
  • Otologic disease: Otitis media and hearing loss occur in approximately 35% of cases (range 19-61%) 3

Lower Respiratory Tract Manifestations

Pulmonary involvement is a cardinal feature of GPA 4, 5:

  • Pulmonary infiltrates and nodules are common findings 2
  • Alveolar hemorrhage can occur in severe cases and represents a life-threatening complication 2
  • Necrotizing granulomatous inflammation of the bronchi and lung parenchyma 4

Renal Manifestations

Kidney involvement is a defining feature that significantly impacts prognosis 1:

  • Glomerulonephritis manifesting as proteinuria, hematuria, and varying degrees of kidney failure 2
  • Pauci-immune necrotizing crescentic glomerulonephritis is the pathologic hallmark 1
  • Elevated serum creatinine indicating renal dysfunction 1
  • The 10-year survival rate is approximately 40% when kidneys are involved versus 60-70% without renal involvement 3

Ocular Manifestations

Eye involvement occurs frequently 2:

  • Scleritis is a common ocular manifestation 2
  • Retro-orbital tumors can develop as part of granulomatous disease 5

Neurological Manifestations

Peripheral nervous system involvement is frequent 2:

  • Peripheral neuropathy with a mononeuritis multiplex pattern 2
  • Pachymeningitis (inflammation of the dura mater) can occur 5

Cutaneous Manifestations

Skin lesions are common but heterogeneous 2:

  • Palpable purpura is the most vasculitis-specific skin lesion 2
  • Various other skin manifestations may occur 2

Systemic Manifestations

Constitutional symptoms are frequently present 2:

  • Arthralgia and myalgia 2
  • Fatigue and weight loss 2
  • Fever may accompany active disease 2

Cardiac Manifestations (Less Common)

Cardiac involvement is infrequent but can occur 6:

  • Cardiac complications represent one of the less common but serious manifestations 6

Important Clinical Pearls

PR3-ANCA (c-ANCA) positivity is present in 80-90% of GPA cases and is highly specific for this diagnosis, though ANCA negativity does not exclude the disease 1, 2. The disease spectrum is heterogeneous, ranging from indolent single-site involvement to fulminant multiorgan vasculitis 4. Without treatment, mean survival is only 5 months, but with modern immunosuppressive therapy, mean survival has improved to 21.7 years from diagnosis 1.

References

Guideline

Granulomatosis with Polyangiitis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Clinical Presentation and Management of Granulomatosis with Polyangiitis (GPA)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinic manifestations in granulomatosis with polyangiitis.

International journal of immunopathology and pharmacology, 2016

Research

Granulomatosis with Polyangiitis (Wegener's Granulomatosis): Evolving Concepts in Treatment.

Seminars in respiratory and critical care medicine, 2018

Research

From Head to Toe: Granulomatosis with Polyangiitis.

Radiographics : a review publication of the Radiological Society of North America, Inc, 2021

Related Questions

What is the clinical description of Granulomatosis with Polyangiitis (GPA)?
Is Granulomatosis with polyangiitis (GPA) caused by an infection?
What is the diagnosis for a patient with a 6-month history of cough, sinusitis, and fever, found to have nasopharyngeal ulceration, nodular and cavity lesions on chest x-ray, positive PR3-ANCA (antineutrophil cytoplasmic antibodies against a cytosolic component), negative ANA (antinuclear antibodies), impaired renal function (elevated serum creatinine), and vasculitis with granulomatous inflammation on lung biopsy?
What is the treatment for Granulomatosis with Polyangiitis (GPA)?
What is granulomatosis with polyangitis?
What are the changes in the diagnosis of cyclothymic disorder across Diagnostic and Statistical Manual of Mental Disorders (DSM) (Diagnostic and Statistical Manual of Mental Disorders) 3, 4, 5, and 5-Text Revision (TR), and International Classification of Diseases (ICD) (International Classification of Diseases) 10 and 11?
What is the significance of burr cells (echinocytes) in a patient's blood smear, particularly in those with a history of renal disease or liver disease?
What is the appropriate management for a patient with chronic kidney disease (CKD) stage 4 or 5, hyperglycemia, anemia, and potential bone disease?
What is the recommended management for a patient with grade 2 burns and unclear or outdated tetanus vaccination history?
When and what dosage of medication, such as levothyroxine (thyroid hormone replacement) or methimazole (antithyroid medication), should be started in a patient with thyroid dysfunction, based on their thyroid function tests, including Thyroid-Stimulating Hormone (TSH) levels, age, and weight?
What are the contraindications for Viagra (sildenafil) in patients, particularly older adults, with a history of myocardial infarction, stroke, or life-threatening arrhythmias, and those with impaired renal function or severe hepatic impairment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.